Stockscreener 앱 받기
1.11
3.74%
0.04
시간 외 거래:
1.09
-0.02
-1.80%
Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스
LUCD News | LUCID DIAGNOSTICS INC (NASDAQ:LUCD) - ChartMill
Director buys 245K Lucid Diagnostics (NASDAQ: LUCD) shares in market - Stock Titan
Lucid Diagnostics Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LUCD) 2026-05-17 - Seeking Alpha
Lucid Diagnostics Inc. (LUCD) reports Q1 loss, misses revenue estimates - MSN
PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ... By GuruFocus - Investing.com Canada
Upcoming Events - FinancialContent
Maxim Group Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Cuts Target Price to $2 - Moomoo
BTIG Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Maintains Target Price $2.5 - Moomoo
PAVmed (PAVM) Q1 2026 Earnings Transcript - AOL.com
PAVmed (PAVM) Q4 2025 Earnings Transcript - The Globe and Mail
PAVmed Reports Q1 2026 Financial Results, Highlights Progress in Veris Health FDA Submission and Lucid Diagnostics Commercial Expansion - Minichart
Earnings Call Summary | Lucid Diagnostics(LUCD.US) Q1 2026 Earnings Conference - 富途牛牛
PAVmed Reports Wider-than-Expected Q1 2026 Loss - AlphaStreet
Earnings call transcript: PAVmed Inc. Q1 2026 shows restructuring gains By Investing.com - Investing.com Australia
Earnings call transcript: PAVmed Inc. Q1 2026 shows restructuring gains - Investing.com India
Q1 2026 PAVmed Inc Earnings Call Transcript - GuruFocus
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2026 Earnings Call Transcript - Insider Monkey
PAVmed (NASDAQ: PAVM) Q1 2026 results, losses and cash position - Stock Titan
PAVmed Q1: cancer test and implantable monitor push toward coverage, FDA - Stock Titan
Canaccord Genuity Sticks to Its Buy Rating for Lucid Diagnostics (LUCD) - The Globe and Mail
Lucid says $44.8M pro forma cash extends runway well into 2027 as it awaits Medicare LCD - MSN
Lucid Diagnostics Inc.Common Stock (NQ: LUCD - FinancialContent
PAVmed Inc.Series Z Warrant (NQ: PAVMZ - FinancialContent
Lucid Diagnostics Earnings Call Balances Progress, Pressure - TipRanks
PAVmed Reports Business Expansion and Financial Update - Intellectia AI
PAVmed (NASDAQ: PAVM) posts Q1 2026 loss and flags going concern risks - Stock Titan
Lucid Diagnostics Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Lucid Diagnostics Releases Q1 2026 Financial Results - AlphaStreet
LUCD Q1 2026 Earnings Transcript - The Globe and Mail
Lucid Diagnostics Q1 Earnings Call Highlights - Yahoo Finance
LUCD: Q1 revenue reached $1.3M on 3,177 tests, with cash runway extended and Medicare approval pending - TradingView
Lucid Diagnostics Reports Q1 2026 Financial Results: $1.3M Revenue, Strong Cash Position, and Medicare Reimbursement Milestone Progress - Minichart
Earnings call transcript: Lucid Diagnostics Q1 2026: Revenue Miss Despite EPS Match - Investing.com
LUCD: Q1 2026 delivered strong test volume, improved cash, and progress toward Medicare and VA revenue - TradingView
Lucid Diagnostics earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Lucid Diagnostics Reports Q1 2026 Results and Outlook - TipRanks
LUCID DIAGNOSTICS ($LUCD) Releases Q1 2026 Earnings - Quiver Quantitative
Lucid Diagnostics (NASDAQ: LUCD) narrows loss and extends cash runway into 2027 - Stock Titan
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results - marketscreener.com
Lucid Diagnostics (LUCD) Q1 Loss Widening To US$23.6 Million Tests Bullish Growth Narrative - Sahm
Lucid Diagnostics 1Q 2026: Revenue $1.26M, EPS ($0.17) — 10-Q Summary - TradingView
LUCD: Q1 2026 saw higher revenue but continued losses, with future viability hinging on reimbursement and capital - TradingView
Lucid Diagnostics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Lucid Diagnostics (NASDAQ: LUCD) grows Q1 revenue but flags going-concern risk - Stock Titan
TradingKey - TradingKey
Fat Pitch FinancialsLucid Diagnostics Inc.Common Stock (Nasdaq:LUCD) Stock Quote - FinancialContent
Lucid Diagnostics Inc. (LUCD) may report negative earnings: Know the trend ahead of next week's release - MSN
Lucid Diagnostics (NASDAQ:LUCD) Stock Rating Lowered by Wall Street Zen - MarketBeat
Lucid Diagnostics Inc. (LUCD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Lucid Diagnostics (LUCD) to Release Earnings on Thursday - MarketBeat
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
Lucid Diagnostics Inc. (LUCD) reports Q4 loss, beats revenue estimates - MSN
1.27%
2.05%
자본화:
|
볼륨(24시간):